MOO "OB'EDINENIE NEYROANESTEZIOLOGOV I NEYROREANIMATOLOGOV", Moscow

Economic indicators

Net profit (RAS) of MOO OB'EDINENIE NEYROANESTEZIOLOGOV I NEYROREANIMATOLOGOV dropped in 2023 91.75 times to 8.00 thousand RUB from 734.00 thousand RUB over the same period in 2022, the company informed.

Revenue decreased in the accounting period ? times to 0.00 thousand RUB from 1.44 million RUB in 2022; cost of goods sold decreased ? times to 0.00 thousand RUB from 621.00 thousand RUB; sales profit made up 0 RUB compared to 819.00 thousand RUB.

Net profit (RAS) of MOO OB'EDINENIE NEYROANESTEZIOLOGOV I NEYROREANIMATOLOGOV dropped in 2022 2.11 times to 734.00 thousand RUB from 1.55 million RUB over the same period in 2021, the company informed.

Revenue decreased in the accounting period 2.19 times to 1.44 million RUB from 3.16 million RUB in 2021.

Net profit (RAS) of MOO OB'EDINENIE NEYROANESTEZIOLOGOV I NEYROREANIMATOLOGOV dropped in 2021 2.51 times to 1.55 million RUB from 3.89 million RUB over the same period in 2020, the company informed.

Revenue decreased in the accounting period by 39.66% to 3.16 million RUB from 5.23 million RUB in 2020.

Net profit (RAS) of MOO OB'EDINENIE NEYROANESTEZIOLOGOV I NEYROREANIMATOLOGOV grew over 2020 by 6.69% to 3.89 million RUB from 3.65 million RUB over 2019, the company informed.

Revenue decreased in the accounting period by 10.92% to 5.23 million RUB from 5.87 million RUB in 2019.

Net profit (RAS) of MOO OB'EDINENIE NEYROANESTEZIOLOGOV I NEYROREANIMATOLOGOV dropped in 2019 2.13 times to 3.65 million RUB from 7.75 million RUB over the same period in 2018, the company informed.

Revenue decreased in the accounting period by 47.49% to 5.87 million RUB from 11.18 million RUB in 2018.

Net profit (RAS) of MOO OB'EDINENIE NEYROANESTEZIOLOGOV I NEYROREANIMATOLOGOV dropped in 2018 by 11.92% to 7.75 million RUB from 8.80 million RUB over the same period in 2017, the company informed.

Revenue decreased in the accounting period by 15.01% to 11.18 million RUB from 13.15 million RUB in 2017; cost of goods sold decreased by 22.21% to 3.05 million RUB from 3.92 million RUB; sales profit fell by 11.95% to 8.13 million RUB from 9.23 million RUB.

Net profit (RAS) of MOO OB'EDINENIE NEYROANESTEZIOLOGOV I NEYROREANIMATOLOGOV grew over 2017 2.39 times to 8.80 million RUB from 3.68 million RUB over 2016, the company informed.

Revenue decreased in the accounting period by 7.83% to 13.15 million RUB from 14.27 million RUB in 2016; cost of goods sold decreased 2.60 times to 3.92 million RUB from 10.19 million RUB; sales profit went up 2.26 times to 9.23 million RUB from 4.08 million RUB.

Net profit (RAS) of MOO OB'EDINENIE NEYROANESTEZIOLOGOV I NEYROREANIMATOLOGOV grew over 2016 by 13.49% to 3.68 million RUB from 3.25 million RUB over 2015, the company informed.

Revenue increased in the accounting period by 12.45% to 14.27 million RUB from 12.69 million RUB over 2015; cost of goods sold grew by 13.49% to 10.19 million RUB from 8.98 million RUB; sales profit went up by 9.93% to 4.08 million RUB from 3.72 million RUB.

Net profit (RAS) of MOO Ob'edinenie neyroanesteziologov i neyrorean grew over 2014 by 2.10% to 1.85 million RUB from 1.81 million RUB over 2013, the company informed.

Revenue increased in the accounting period by 17.25% to 13.73 million RUB from 11.71 million RUB over 2013; cost of goods sold grew by 17.96% to 11.12 million RUB from 9.43 million RUB; sales profit went up by 14.32% to 2.60 million RUB from 2.28 million RUB.

Net profit (RAS) of MOO Obedinenie neyroanesteziologov i neyrorean dropped in 2013 by 35.16% to 1.81 million RUB from 2.79 million RUB over the same period in 2012, the company informed.

Revenue decreased in the accounting period by 11.20% to 11.71 million RUB from 13.18 million RUB in 2012; cost of goods sold decreased by 2.59% to 9.43 million RUB from 9.68 million RUB; sales profit fell by 35.00% to 2.28 million RUB from 3.50 million RUB.

Companies in the region

• URALSTROY FINANS
• RSOO "FPSSO"
• MERSI
• YARKIE LYUDI
• BETTA